FR2445142A1 - ANTITHROMBOTIC THERAPEUTIC COMPOSITION - Google Patents

ANTITHROMBOTIC THERAPEUTIC COMPOSITION

Info

Publication number
FR2445142A1
FR2445142A1 FR7928799A FR7928799A FR2445142A1 FR 2445142 A1 FR2445142 A1 FR 2445142A1 FR 7928799 A FR7928799 A FR 7928799A FR 7928799 A FR7928799 A FR 7928799A FR 2445142 A1 FR2445142 A1 FR 2445142A1
Authority
FR
France
Prior art keywords
therapeutic composition
activity
antithrombotic therapeutic
antithrombotic
constituents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7928799A
Other languages
French (fr)
Other versions
FR2445142B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of FR2445142A1 publication Critical patent/FR2445142A1/en
Application granted granted Critical
Publication of FR2445142B1 publication Critical patent/FR2445142B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

L'invention a pour objet une composition thérapeutique contenant, à titre de principe actif, une association d'un dérivé de pyridine à activité antiagrégante plaquettaire et d'un composé ayant une activité de blocage des récepteurs beta . Cette composition présente une puissante activité antithrombotique due à un effet de synergie entre ses deux constituants.A subject of the invention is a therapeutic composition containing, as active principle, a combination of a pyridine derivative with antiplatelet activity and a compound having beta receptor blocking activity. This composition exhibits a powerful antithrombotic activity due to a synergistic effect between its two constituents.

FR7928799A 1978-12-29 1979-11-22 ANTITHROMBOTIC THERAPEUTIC COMPOSITION Granted FR2445142A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7850360A GB2038178B (en) 1978-12-29 1978-12-29 Antithrombotic therapeutic compsition

Publications (2)

Publication Number Publication Date
FR2445142A1 true FR2445142A1 (en) 1980-07-25
FR2445142B1 FR2445142B1 (en) 1981-09-11

Family

ID=10502011

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7928799A Granted FR2445142A1 (en) 1978-12-29 1979-11-22 ANTITHROMBOTIC THERAPEUTIC COMPOSITION

Country Status (8)

Country Link
JP (1) JPS5592318A (en)
BE (1) BE880885A (en)
DE (1) DE2951669C2 (en)
FR (1) FR2445142A1 (en)
GB (1) GB2038178B (en)
IE (1) IE48883B1 (en)
IL (1) IL58816A (en)
IT (1) IT1162497B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI101150B (en) * 1991-09-09 1998-04-30 Sankyo Co Process for the preparation of tetrahydrothione nopyridine derivatives useful as a drug
WO1999065500A1 (en) * 1998-06-17 1999-12-23 Bristol-Myers Squibb Company Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2215948A1 (en) * 1973-02-01 1974-08-30 Centre Etd Ind Pharma
FR2307538A1 (en) * 1975-04-18 1976-11-12 Centre Etd Ind Pharma NEW PLATELET ANTI-AGGREGANT DRUG

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2215948A1 (en) * 1973-02-01 1974-08-30 Centre Etd Ind Pharma
FR2307538A1 (en) * 1975-04-18 1976-11-12 Centre Etd Ind Pharma NEW PLATELET ANTI-AGGREGANT DRUG

Also Published As

Publication number Publication date
IE48883B1 (en) 1985-06-12
FR2445142B1 (en) 1981-09-11
DE2951669A1 (en) 1980-07-17
IL58816A (en) 1982-07-30
IE792280L (en) 1980-06-29
GB2038178B (en) 1983-03-09
BE880885A (en) 1980-06-27
JPS5592318A (en) 1980-07-12
IT7951222A0 (en) 1979-12-28
IT1162497B (en) 1987-04-01
GB2038178A (en) 1980-07-23
IL58816A0 (en) 1980-02-29
JPS6150925B2 (en) 1986-11-06
DE2951669C2 (en) 1985-08-22

Similar Documents

Publication Publication Date Title
FR2406641A1 (en) 2,6-DIAMINONEBULARINS AND THEIR THERAPEUTIC APPLICATION
FR2430410A1 (en) PHENETHANOLAMINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
EP0002916A3 (en) The use of milbemycin compounds as anthelmintic agents and anthelmintic compositions containing such compounds
FR2571966B1 (en) THERAPEUTIC COMPOSITIONS CONTAINING ANTHRACYCLINES-GLUCOSIDES.
FR2417510A1 (en) 9-AMINO- AND IMINO-DIBENZOPYRANS AND THEIR THERAPEUTIC USE
FR2434156A2 (en) QUATERNARY IMIDAZOLIUM COMPOUNDS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS, ESPECIALLY MICROBICIDES CONTAINING THEM
FR2387229A1 (en) DIPYRIDO (4,3-B) (3,4-F) INDOLES, PROCESS FOR OBTAINING, THERAPEUTIC APPLICATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ES478967A1 (en) 3,7-Disubstituted-3-cephem-4-carboxylic acid compounds
FR2430408A1 (en) OPTICALLY ACTIVE PHENETHANOLAMINES AND THEIR THERAPEUTIC USE
FR2387988A1 (en) CEFUROXIME ESTERS, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
ES8307496A1 (en) Galenic preparation.
FR2445143A1 (en) THERAPEUTIC COMPOSITION WITH ANTITHROMBOTIC ACTIVITY AND PLATELET ANTIAGGREGANT
FR2420344A1 (en) NEW OXIME-ETHERS, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION.
FR2445142A1 (en) ANTITHROMBOTIC THERAPEUTIC COMPOSITION
FR2421179A1 (en) 3-0- (B-D-GLUCURONOPYRANNOSYL) -SOYASAPOGENOL B, ITS PREPARATION AND ITS THERAPEUTIC USES
FR2422667A1 (en) 7A-METHOXYCEPHALOSPORIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
BE860162A (en) ACTIVE DERIVATIVES OF UREA THEIR PROCESS OF PREPARATION AS WELL AS THE THERAPEUTIC COMPOSITIONS CONTAINING THEM
BE888525A (en) NUCLEOSIDE OF THE DESAZAPURINS CLASS, COMPOSITIONS CONTAINING THEM AND THEIR APPLICATION IN MEDICINE,
FR2368489A1 (en) CLAVULIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
FR2419291A1 (en) 2,3-DIHYDROIMIDAZO (1,2-C) SUBSTITUTED PYRIMIDINES AND THEIR THERAPEUTIC USE
FR2359838A1 (en) GUANIDINS, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS
FR2389624A1 (en)
FR2399406A1 (en) PERHYDRONAPHTALENEPENTOL DERIVATIVES AND THEIR THERAPEUTIC USE
FR2369245A1 (en) TRICYCLIC COMPOUNDS WITH BIOLOGICAL ACTIVITY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE2967276D1 (en) 2-aryl-1,3-indandione derivatives and compositions comprising them for controlling ectoparasitic acarina

Legal Events

Date Code Title Description
TP Transmission of property